Cell-free method of producing synthetic circular nucleic acid
Inventors
RUSSART, Nathan • INDURTHI, Venkata • Arutyunov, Denis
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present disclosure relates to a process of cell-free circular nucleic acid amplification using rolling circle amplification.
Core Innovation
The invention provides methods for cell-free production of synthetic circular nucleic acids from a circular nucleic acid template comprising a backbone and an insert sequence. The workflow employs rolling-circle amplification, endonuclease digestion of the amplification product at insert-associated cut sites, and ligation to generate a circular ligation product. Reaction mixtures are further subjected to exonuclease treatment and purification to yield synthetic circular nucleic acid substantially free of linear nucleic acid.
The process provides a cost-effective route to high-purity circular nucleic acids without host-cell-derived contaminants. Gradual substrate addition during ligation is reported to increase circular monomer production compared with traditional ligation. The text also notes that tested endonucleases can be inactivated while preserving DNA for subsequent ligation, and products may undergo backbone-directed digestion and topoisomerase-mediated supercoiling.
Claims Coverage
The claim coverage includes two independent claims, claim 1 and claim 13, encompassing six inventive features directed to producing synthetic circular nucleic acid through amplification, digestion, ligation, removal of unwanted nucleic acids, and purification.
Circular template amplification
Both independent claims recite rolling-circle amplification of a circular nucleic acid template comprising a backbone and an insert sequence to generate an amplification product, with claim 13 specifying Phi29 DNA polymerase.
Insert-directed endonuclease digestion
Both claims cover digestion of the amplification product at endonuclease cut sites associated with the insert sequence to produce a first digestion product.
Ligation with gradual substrate addition
The claims cover ligation of the digestion product to generate a circular ligation product that is at least partially supercoiled, with claim 1 specifying adding digestion product over time and claim 13 specifying T4 DNA ligase.
Second backbone-directed digestion
Claim 13 recites a second digestion targeting internal cut sites on the backbone using an endonuclease with a recognition site different from that of the first endonuclease.
Exonuclease treatment to remove unwanted nucleic acids
The claims recite exonuclease treatment to digest single-stranded, linear, and open-circle nucleic acids, producing synthetic circular nucleic acid substantially free of linear nucleic acid.
Purification of the reaction product
Both claims include purification of the final reaction product to obtain the synthetic circular nucleic acid, with claim 13 specifying ion-exchange chromatography.
Together, the independent claims cover circular template amplification, insert-directed digestion, ligation, exonuclease removal of unwanted nucleic acids, and purification, with claim 13 additionally reciting specified reagents, a second backbone digestion, and ion-exchange chromatography.
Stated Advantages
Gradual substrate addition during ligation increased circular monomer production by 158% compared with traditional ligation.
The process is presented as a cost-effective route to producing high-purity circular nucleic acid.
The process produces synthetic circular nucleic acid without host-cell-derived contaminants.
Documented Applications
Production and purification of synthetic circular nucleic acids.
Therapeutic applications for synthetic circular nucleic acids.
Diagnostic applications for synthetic circular nucleic acids.
Research applications for synthetic circular nucleic acids.
Interested in licensing this patent?